Maverick Capital
Maverick Capital is a $10 billion hedge fund and has long been known as one of the largest and most consistently successful hedge funds. The fund was started in 1993 by Lee S. Ainslie III, who was a protege of Julian Robertson at Tiger Management. The fund only invests in equities and maintains a balance of long and short positions. The most common valuation method Maverick uses is comparing sustainable free cash flow to enterprise value. Maverick seeks to hold stocks between 1 and 3 years.
View Older Stories View More Recent Stories
-
Young Jewish Professionals Honor CBRE Global Brokerage Chairman Stephen Siegel, Among Others, at Annual YJP Founders’ Gala
-
Science Exchange Adds Allergan EVP & Chief R&D Officer David Nicholson to Its Board of Directors
-
Science Exchange Appoints Two New Executives to Accelerate Growth
-
Science Exchange First & Only R&D Outsourcing Platform to Achieve HIPAA Compliance
-
Pharmacelera Chooses Science Exchange As Its Primary Online Channel To Offer Proprietary Computational Chemistry Services
-
EY Names Elizabeth Iorns of Science Exchange As Entrepreneur Of The Year® 2018 Award Finalist in Northern California
-
Highlights: Hedge funds chomped on FAANGs during first quarter tech turmoil
-
Form 13F-HR MAVERICK CAPITAL LTD For: Mar 31
-
Young Jewish Professionals (YJP) to Host Flagship Real Estate Deal-Makers Conference in New York City
-
ACADIA Pharmaceuticals Announces Appointment of Elena Ridloff, CFA, as Senior Vice President, Investor Relations
-
Madison Realty Capital Provides $35 Million Mezzanine Loan for 611 West 56th Street Condominium Development in Hell's Kitchen
-
Madison Realty Capital Provides $35 Million Mezzanine Loan for 611 West 56th Street Condominium Development in Hell’s Kitchen
-
Madison Realty Capital Provides $35 Million Mezzanine Loan for 611 West 56th Street Condominium Development in Hell’s Kitchen
-
FYR Diagnostics Joins Forces With Science Exchange to Offer RNA Screening and Biomarker Services
-
Science Exchange and Ranomics Collaborate to Offer Online Access to their VariantFindTM Mutagenesis Platform
-
Chelonia SA Chooses Science Exchange as the Primary Online Channel to Offer Research Consulting Services to Scientists
-
Science Exchange and Murray Rheology Consulting Collaborate to Offer Online Access to Rheology Services
-
PhenoSwitch Chooses Science Exchange as the Primary Online Channel to Offer LC-MS/MS proteomics services to Scientists
-
Phenovista Chooses Science Exchange as the Primary Online Channel to Offer Phenotypic Assays to Scientists
-
CARE Research, LLC Chooses Science Exchange as the Primary Online Channel to Offer Preclinical In Vivo Services to Scientists
-
Likarda Chooses Science Exchange as the Primary Online Channel to Offer 3D Compound Screening and Assay Development Services to Scientists
-
Form 13F-HR MAVERICK CAPITAL LTD For: Dec 31
-
Form SC 13G/A CASTLIGHT HEALTH, INC. Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A Sabre Corp Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A UNIVERSAL HEALTH SERVICE Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A CommScope Holding Compan Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G Envision Healthcare Corp Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G IMPAX LABORATORIES INC Filed by: MAVERICK CAPITAL LTD
-
Science Exchange Announces Outsourced R&D Collaboration with UC Davis Venture Catalyst Group
-
OnRamp BioInformatics Partners with Science Exchange to Provide the Fastest Path to Interactive Genomic Analysis Services
-
Novaseek Research Partners with Science Exchange to Broaden Access to Its CDNR Platform for Biomedical and Clinical Research
-
Agilent Partners with Science Exchange
-
Rapid Novor Inc. Launches REmAb™ Antibody Protein Sequencing Services on Science Exchange
-
Nanome Partners with Science Exchange to Offer Virtual Reality Drug Design Tools and Blockchain Solutions to Scientists
-
Science Exchange Partners with Lab Launch to Help its Startups Advance Scientific Innovations
-
Breakout Labs Partners with Science Exchange to Empower its Portfolio Companies with External Research Innovations
-
'Tiger Cub' Griffin shuts his Blue Ridge hedge fund after 21 years
-
Bioinformatics Solutions, Inc. Chooses Science Exchange as the Primary Online Channel to Offer Protein de novo Sequencing Services to Scientists
-
Wind turbine makers and Shell lift European shares
-
University of Chicago wins 13th annual Alpha Challenge at UNC Kenan-Flagler Business School
-
Science Exchange Wins Two Gold Stevie® Awards in 2017 Stevie Awards for Women in Business
-
Science Exchange Announces Outsourced R&D Partnership with Alector
-
Elizabeth Iorns, Ph.D., CEO of Science Exchange Elected to the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)
-
Form 13F-HR MAVERICK CAPITAL LTD For: Sep 30
-
Science Exchange Scientific Provider Elion Labs presenting New Research at the AAPS Annual Meeting: Breakthrough in Drug Product Particle Analysis Using Machine Learning
-
REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
-
Partners Capital Focuses on 'Investing During Periods of Political Turmoil' at Second Annual Client Meeting
-
Science Exchange Announces New Director of Scientific Content, Gursatya “Guru” Singh
-
Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange, Named 2017 Scrip Award Executive of the Year Finalist

